W.O.M. World of Medicine AG

euro adhoc: W.O.M. World of Medicine AG
WORLD OF MEDICINE signs exclusive distributor agreement for cancer diagnostic probe Gamma Finder® in USA and Canada/ Guaranteed purchasing quantities of US$ 7.6 million until 2008 (E)

--------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. ---------------------------------------------------------------------

(Berlin, June 13, 2003) W.O.M. WORLD OF MEDICINE AG, listed on the Prime Standard, signed an exclusive Distributor Agreement with a California company.

The Agreement grants distribution rights regarding the FDA (Food and Drug Administration) approved and patented Gamma Finder® device. The Gamma Finder® is a unique, handheld and wireless probe for the detection of cancerous lymph nodes.  

The device identifies cancerous lymph nodes inside the body and prevents the need for removal of cancer-free lymph nodes.  

Our distribution partner agreed to guarantee a minimum purchase volume of US$ 7.6 million within the next five years. The distribution rights are limited to the USA and Canada and to breast and skin cancer applications.

Our American partner develops, manufactures and distributes minimal invasive devices for diagnosis of breast and skin cancer. The Gamma Finder® device with accessories from WORLD OF MEDICINE fits seamlessly into its existing range of products. The significant sales experience of the distributor in the particular fields of application allows even faster access for WORLD OF MEDICINE to the US-market. WORLD OF MEDICINE is investigating further applications for the Gamma Finder® device in the human body.    

W.O.M. WORLD OF MEDICINE AG

The Management Board

end of announcement            euro adhoc 13.06.2003
---------------------------------------------------------------------

Further inquiry note: Contact: Wilma Mitzlaff, wilma.mitzlaff@womcorp.com, Tel.: +49 (30) 399 81 526

Branche: Pharmaceuticals
ISIN:      DE0006637390
WKN:        663739
Index:    Prime Standard
Börsen:  Frankfurter Wertpapierbörse / regulated dealing
              Niedersächsische Börse zu Hannover / free trade
              Berliner Wertpapierbörse / free trade
              Bayerische Börse / free trade
              Hamburger Wertpapierbörse / free trade
              Bremer Wertpapierbörse (BWB) / free trade
              Börse Düsseldorf / free trade
              Baden-Württembergische Wertpapierbörse / free trade



Weitere Meldungen: W.O.M. World of Medicine AG

Das könnte Sie auch interessieren: